Patient Blood Management for Neonates and Children Undergoing Cardiac Surgery: 2019 NATA Guidelines

J Cardiothorac Vasc Anesth. 2019 Dec;33(12):3249-3263. doi: 10.1053/j.jvca.2019.03.036. Epub 2019 Mar 20.

Abstract

Pediatric cardiac surgery is associated with a substantial risk of bleeding, frequently requiring the administration of allogeneic blood products. Efforts to optimize preoperative hemoglobin, limit blood sampling, improve hemostasis, reduce bleeding, correct coagulopathy, and incorporate blood sparing techniques (including restrictive transfusion practices) are key elements of patient blood management (PBM) programs, and should be applied to the pediatric cardiac surgical population as across other disciplines. Many guidelines for implementation of PBM in adults undergoing cardiac surgery are available, but evidence regarding the implementation of PBM in children is limited to systematic reviews and specific guidelines for the pediatric cardiac population are missing. The objective of the task force from the Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis (NATA, www.nataonline.com) is to provide evidence-based recommendations regarding anemia management and blood transfusion practices in the perioperative care of neonates and children undergoing cardiac surgery, and to highlight potential areas where additional research is urgently required.

Keywords: bleeding; congenital heart surgery; guidelines; patient blood management; pediatrics; transfusion.

Publication types

  • Systematic Review

MeSH terms

  • Antifibrinolytic Agents / therapeutic use*
  • Blood Loss, Surgical / prevention & control
  • Blood Transfusion / methods*
  • Cardiac Surgical Procedures*
  • Heart Defects, Congenital / surgery*
  • Hemorrhage / prevention & control*
  • Humans
  • Infant, Newborn
  • Perioperative Care / methods*
  • Postoperative Hemorrhage / prevention & control
  • Practice Guidelines as Topic*

Substances

  • Antifibrinolytic Agents